A New Look At the Mosaic Theory of Hypertension.
作者信息
Touyz Rhian M, Feldman Ross D, Harrison David G, Schiffrin Ernesto L
机构信息
Institute of Cardiovascular and Medical Sciences, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom.
Departments of Medicine, Physiology and Pathophysiology, and Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada; Cardiac Sciences Program, Winnipeg Regional Health Authority, Winnipeg, Manitoba, Canada.
出版信息
Can J Cardiol. 2020 May;36(5):591-592. doi: 10.1016/j.cjca.2020.03.025. Epub 2020 Mar 29.
Abstract
摘要
相似文献
1
A New Look At the Mosaic Theory of Hypertension.高血压镶嵌理论新视角
Can J Cardiol. 2020 May;36(5):591-592. doi: 10.1016/j.cjca.2020.03.025. Epub 2020 Mar 29.
2
Insulin resistance and hypertension--implications for treatment.胰岛素抵抗与高血压——治疗的意义
Postgrad Med J. 1991 Oct;67(792):869-75. doi: 10.1136/pgmj.67.792.869.
3
Workshop III--Insulin resistance: is it truly the link?研讨会三——胰岛素抵抗：它真的是关联因素吗？
Am J Med. 1991 Feb 21;90(2A):26S-31S. doi: 10.1016/0002-9343(91)90033-t.
4
The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress.高血压中的肾素-血管紧张素-醛固酮系统：胰岛素抵抗和氧化应激的作用
Med Clin North Am. 2009 May;93(3):569-82. doi: 10.1016/j.mcna.2009.02.014.
5
[Arterial hypertension in patients with obesity. Role of hyperinsulinism and insulin resistance].[肥胖患者的动脉高血压。高胰岛素血症和胰岛素抵抗的作用]
Rev Med Interne. 1990 Jul-Aug;11(4):293-6. doi: 10.1016/s0248-8663(05)80861-6.
6
Insulin resistance in systemic hypertension: pharmacotherapeutic implications.系统性高血压中的胰岛素抵抗：药物治疗意义
J Clin Pharmacol. 1995 Oct;35(10):943-56. doi: 10.1002/j.1552-4604.1995.tb04010.x.
7
Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases.交感神经系统作为与衰老和肥胖相关的心血管疾病的靶点。
Geroscience. 2019 Feb;41(1):13-24. doi: 10.1007/s11357-018-0048-5. Epub 2018 Dec 5.
8
[Function of Perivascular Nerves in Insulin Resistance-induced Hypertension].[血管周围神经在胰岛素抵抗诱导的高血压中的作用]
Yakugaku Zasshi. 2017;137(11):1367-1371. doi: 10.1248/yakushi.17-00149.
9
Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.高胰岛素血症和胰岛素抵抗在高血压中的作用：重新审视代谢综合征。
Can J Cardiol. 2020 May;36(5):671-682. doi: 10.1016/j.cjca.2020.02.066. Epub 2020 Feb 12.
10
Rostral Ventrolateral Medulla and Hypertension.延髓头端腹外侧与高血压
Hypertension. 2018 Sep;72(3):559-566. doi: 10.1161/HYPERTENSIONAHA.118.10921.
引用本文的文献
1
Cardiovascular Assessments in Children and Adolescents With Hypertension.高血压儿童和青少年的心血管评估
Rev Cardiovasc Med. 2025 Aug 25;26(8):39498. doi: 10.31083/RCM39498. eCollection 2025 Aug.
2
Relationship between serum copeptin levels and non-invasive endothelial function indicators in dipper and non-dipper hypertensive patients.勺型和非勺型高血压患者血清 copeptin 水平与无创内皮功能指标之间的关系
Am J Cardiovasc Dis. 2025 Jun 15;15(3):156-165. doi: 10.62347/TSLN4765. eCollection 2025.
3
Pathophysiology of primary hypertension in children and adolescents.儿童和青少年原发性高血压的病理生理学。
Pediatr Nephrol. 2024 Jun;39(6):1725-1737. doi: 10.1007/s00467-023-06142-2. Epub 2023 Sep 13.
4
Circulating Levels of Endothelin-1 and Big Endothelin-1 in Patients with Essential Hypertension.原发性高血压患者血浆内皮素-1和大内皮素-1水平
Pathophysiology. 2021 Oct 25;28(4):489-495. doi: 10.3390/pathophysiology28040031.
5
The Causal Relationship between Endothelin-1 and Hypertension: Focusing on Endothelial Dysfunction, Arterial Stiffness, Vascular Remodeling, and Blood Pressure Regulation.内皮素-1与高血压之间的因果关系：聚焦于内皮功能障碍、动脉僵硬度、血管重塑和血压调节
Life (Basel). 2021 Sep 20;11(9):986. doi: 10.3390/life11090986.
本文引用的文献
1
Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure.靶向脑氨肽酶 A：高血压和心力衰竭治疗的新策略。
Can J Cardiol. 2020 May;36(5):721-731. doi: 10.1016/j.cjca.2020.03.005. Epub 2020 Mar 6.
2
Sympathetic Nervous System Contributions to Hypertension: Updates and Therapeutic Relevance.交感神经系统对高血压的影响：最新研究进展及其治疗相关性。
Can J Cardiol. 2020 May;36(5):712-720. doi: 10.1016/j.cjca.2020.03.003. Epub 2020 Mar 6.
3
Sex-Specific Determinants of Coronary Artery Disease and Atherosclerotic Risk Factors: Estrogen and Beyond.性别特异性冠状动脉疾病与动脉粥样硬化危险因素：雌激素及其他因素。
Can J Cardiol. 2020 May;36(5):706-711. doi: 10.1016/j.cjca.2020.03.002. Epub 2020 Mar 6.
4
Genomics of Blood Pressure and Hypertension: Extending the Mosaic Theory Toward Stratification.血压和高血压的基因组学：将马赛克理论扩展到分层。
Can J Cardiol. 2020 May;36(5):694-705. doi: 10.1016/j.cjca.2020.03.001. Epub 2020 Mar 5.
5
The Renin-Angiotensin System in Hypertension, a Constantly Renewing Classic: Focus on the Angiotensin AT-Receptor.高血压中的肾素-血管紧张素系统：不断更新的经典——关注血管紧张素 AT 受体。
Can J Cardiol. 2020 May;36(5):683-693. doi: 10.1016/j.cjca.2020.02.095. Epub 2020 Mar 5.
6
Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.高胰岛素血症和胰岛素抵抗在高血压中的作用：重新审视代谢综合征。
Can J Cardiol. 2020 May;36(5):671-682. doi: 10.1016/j.cjca.2020.02.066. Epub 2020 Feb 12.
7
Oxidative Stress: A Unifying Paradigm in Hypertension.氧化应激：高血压的统一范式。
Can J Cardiol. 2020 May;36(5):659-670. doi: 10.1016/j.cjca.2020.02.081. Epub 2020 Feb 24.
8
How Structure, Mechanics, and Function of the Vasculature Contribute to Blood Pressure Elevation in Hypertension.血管的结构、力学和功能如何导致高血压中的血压升高。
Can J Cardiol. 2020 May;36(5):648-658. doi: 10.1016/j.cjca.2020.02.003. Epub 2020 Feb 8.
9
Inflammation in Hypertension.高血压中的炎症反应。
Can J Cardiol. 2020 May;36(5):635-647. doi: 10.1016/j.cjca.2020.01.013. Epub 2020 Jan 24.
10
Hypertension Canada's 2020 Evidence Review and Guidelines for the Management of Resistant Hypertension.加拿大高血压协会 2020 年耐药性高血压证据综述和管理指南。
Can J Cardiol. 2020 May;36(5):625-634. doi: 10.1016/j.cjca.2020.02.083.
Zotero 插件